Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial

INTRODUCTION: End stage renal failure patients on hemodialysis have significant vascular calcification This is postulated to be related to sub-clinical vitamin K deficiency, which is prevalent in hemodialysis patients. Vitamin K deficiency result in the failure of the matrix GLA protein (MGP) to und...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Medicine (Baltimore)
Glavni autori: Haroon, Sabrina-Wong-Peixin, Tai, Bee-Choo, Ling, Lieng-Hsi, Teo, Lynette, Davenport, Andrew, Schurgers, Leon, Teo, Boon-Wee, Khatri, Priyanka, Ong, Ching-Ching, Low, Sanmay, Yeo, Xi-Er, Tan, Jia-Neng, Subramanian, Srinivas, Chua, Horng-Ruey, Tan, Swee-Yaw, Wong, Weng-Kin, Lau, Titus-Wai-Leong
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2020
Teme:
5200
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7478798/
https://ncbi.nlm.nih.gov/pubmed/32899022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021906
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items